is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

New Polyethylene for Knee-Implant System Cleared by FDA

Article-New Polyethylene for Knee-Implant System Cleared by FDA

Peter Dazeley/The Image Bank via Getty Images aching knee
The chemically cross-linked polyethylene with vitamin E antioxidant does not require gamma sterilization, unlike previous formulations.

Orthopedic implant and instrument company Exactech announced on Aug. 21 that it has received 510(k) clearance from FDA for its new Activit-E polyethylene (PE) for the Truliant knee-replacement system. The new PE with vitamin E antioxidant does not require gamma sterilization, unlike previous formulations of the material.

“After years of research and development in polyethylene, Activit-E represents a breakthrough achievement for Exactech,” said Adam Hayden, chief marketing officer and senior vice president of the Large Joints Business Unit at Exactech. “It is the next generation of highly cross-linked polyethylene with vitamin E antioxidant that is intended to further our primary goal of providing immense benefits to our patients.”

Image courtesy of ExactechActivit-E knee implant system

The chemically cross-linked polyethylene brings strength, toughness, oxidative resistance, and long-term performance to the Truliant knee-replacement system.

The chemically cross-linked PE reportedly brings an optimized balance of material strength and toughness without requiring the use of gamma sterilization. The material is designed to maintain active oxidative resistance and long-term performance, including strength and stabilization, according to Exactech.

The PE was developed by Orhun Muratoglu, PhD, director of the Harris Orthopaedic Laboratory at Massachusetts General Hospital in Boston. Muratoglu invented the first cross-linked PE, and the first of multiple generations of vitamin E, antioxidant PE for leading orthopedic companies, said the news release.

“We replaced gamma radiation cross linking with peroxide cross linking and stabilized the poly with vitamin E to provide strength, flexibility, and toughness where it is needed most — total knee arthroplasty,” said Muratoglu. “This technology also addressed the looming shortage of gamma radiation for cross-linking, ensuring that patients will continue to benefit from the clinically proven advantages of highly cross-linked polyethylene in total joints,” said Muratoglu.

As reported in sister media outlet MD+DI, in recent years there has been tightness in the supply of cobalt-60, the radioactive isotope that generates the gamma radiation used to sterilize healthcare products. Core to the process, cobalt-60 is produced in a handful of nuclear reactors and specialized suppliers. The shortage is a result of increasing demand and the decision of one state-run corporation to reduce output, reported MD+DI.

Activit-E launched in the beginning of Q3 2023 for select US customers, with global expansion set to start in 2024.

Based in Gainesville, FL, Exactech develops and markets orthopedic implant devices, related surgical instruments, and the Active Intelligence platform of smart technologies to hospitals and physicians.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
The Plastics Industry Is Under Attack

Environmental concerns about plastics are valid, but politicians and corporations often cow to activists without considering that they can be a sustainable choice in many applications.

We're tracking the industry's fight to ensure common sense prevails.